MétaCan
Menu
Back to cohort
Record W2413530233 · doi:10.1093/ofid/ofv133.896

The Activity of Tedizolid Against Gram-Positive Pathogens Isolated From Patients in USA Medical Centers: 2014 Surveillance

2015· article· en· W2413530233 on OpenAlexaboutno aff
David J. Farrell, Robert K. Flamm, Rodrigo E. Mendes, Ronald N. Jones

Bibliographic record

VenueOpen Forum Infectious Diseases · 2015
Typearticle
Languageen
FieldMedicine
TopicAntimicrobial Resistance in Staphylococcus
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineGramPathogenic organismGram-positive bacterial infectionsMicrobiologyTraditional medicineVirologyAntibioticsBiologyBacteria

Abstract

fetched live from OpenAlex

Background. Tedizolid (TZD) is approved for treatment of acute bacterial skin and skin structure infections in the United States of America (USA), European Union (EU), and Canada. The in vitro activity of TZD was tested against Gram-positive pathogens isolated collected from USA medical centers in 2014. Methods. In 2014, 5999 Gram-positive, non-duplicate, non-consecutive, single patient clinical isolates were collected from 29 medical centers across all nine USA census regions. Isolates were tested for antibacterial susceptibility (S) as per CLSI guidelines. MIC values for TZD and linezolid (LZD) were read both at (1) the first well where trailing begins (80% read; TZD80 and LZD80) as per CLSI M07-A10 and (2) at endpoint (100% growth inhibition; TZD100 and LZD100). USA-FDA, CLSI, and EUCAST breakpoints were used to determine %S. Results. A total of 3441 S. aureus strains were evaluated; 100% of strains were S to TZD. The MIC50/90 values for TZD80 (MIC50/90, 0.12/0.12 µg/mL) were one dilution lower than TZD100 (0.25/0.25 µg/mL) and four-fold lower than for LZD (LZD80, MIC50/90, 1/1 µg/mL; LZD100, MIC50/90, 1/2 µg/mL). Against 344 coagulase-negative staphylococci, TDZ80/100 (MIC50/90, 0.06-0.12/0.12-0.25 µg/mL) was four- to eight-fold more potent than LZD80/100 (MIC50/90, 0.5-1/0.5-1 µg/mL). TZD was active (80/100 MIC90, 0.25/0.5 µg/mL) against 524 Enterococcus spp. and 100.0% of 343 E. faecium isolates were S by USA-FDA breakpoint of ≤0.5 µg/mL (using TZD100). Against 563 β-hemolytic streptococci, 100.0% of isolate were S to LZD100 (MIC50/90, 1/1 µg/mL) and TZD100 (MIC50/90, 0.12/0.25 µg/mL). Against 260 viridans group streptococci, 100.0% of isolate were S to LZD100 (MIC50/90, 0.5/1 µg/mL) and TZD100 was two- to four-fold more potent (MIC50/90, 0.12/0.25 µg/mL).TZD100 was also very active (MIC50/90, 0.25/0.25 µg/mL) against 867 pneumococcal isolates. Conclusion. TZD demonstrated higher in vitro activity (two- to four-fold) than LZD when tested against Gram-positive pathogens isolated from patients in USA medical centers during 2014. MIC distributions and MIC50/90 values for TZD and LZD read without regard for pinpoint trailing colonies were one dilution lower than those read at 100% inhibition. Disclosures. D. J. Farrell, Merck & Co. Inc: Research Contractor, Research support; R. K. Flamm, Merck & Co. Inc: Research Contractor, Research support; R. E. Mendes, Merck & Co. Inc: Research Contractor, Research support; R. N. Jones, Merck & Co. Inc: Research Contractor, Research support.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.012
Threshold uncertainty score0.691

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.278
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicAntimicrobial Resistance in StaphylococcusFrench-language works237,207